- Presented at ASHP Midyear 2013
- Alev H. Gulum, Pharm.D., Candidate, Danielle M. Ouellette, Pharm.D. Candidate
Research
- In 2013, over five million individuals in the United States (US) over the age of 20 have been diagnosed with heart failure (HF)
- The prevalence of HF is projected to increase 25% by 2030 and the cost of hospitalizations due to HF will increase 120% to nearly 70 billion dollars. Survival has improved over time with advancements in medical care; however the 5-year survival rate of patients after diagnosis is only 50%.
- African Americans have the highest HF prevalence and age-adjusted incidence of developing HF compared with Hispanic, Caucasian, and Chinese Americans.
- Low serum and dietary magnesium intake are established risk factors for cardiac arrest, fatal coronary heart disease, stroke, insulin resistance, type 2 diabetes mellitus, hypertension, and sudden cardiac death.
- An inverse association has been established with magnesium intake and these risk factors for HF such as hypertension, diabetes, and dyslipidemia; however, little is known regarding the relationship